Okey Stephanie
Insider CIK 1742616 · PTCT Director · ALBO Director · CTLT Director · CRNX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 25,000 | $60.85 | $1.52M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 12,500 | $61.77 | $772.1K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 17,500 | $64.77 | $1.13M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 17,500 | $64.68 | $1.13M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 12,500 | $40.29 | $503.6K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 10,350 | $52.67 | $545.1K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 9,730 | $49.13 | $478.0K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer | 2026-09-01 | 2026-09-01 | 5,925 | $85.00 | $503.6K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer | 2026-09-01 | 2026-09-01 | 6,400 | $85.00 | $544.0K | 5,925 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 9,730 | $49.13 | $478.0K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 10,350 | $52.67 | $545.1K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 12,500 | $40.29 | $503.6K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 17,500 | $64.68 | $1.13M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 17,500 | $64.77 | $1.13M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 12,500 | $61.77 | $772.1K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 25,000 | $60.85 | $1.52M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer | 2026-09-01 | 2026-09-01 | 5,925 | $85.00 | $503.6K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer | 2026-09-01 | 2026-09-01 | 6,400 | $85.00 | $544.0K | 5,925 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2026-06-18 | 2026-06-22 | 9,730 | — | $0 | 9,730 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award | 2026-06-18 | 2026-06-22 | 5,925 | — | $0 | 12,325 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2026-06-17 | 2026-06-18 | 6,292 | $35.62 | $224.1K | 7,008 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2026-06-17 | 2026-06-18 | 608 | $36.22 | $22.0K | 6,400 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | M Exercise deriv | 2026-03-10 | 2026-03-12 | 14,000 | — | $0 | 0 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | M Exercise deriv | 2026-03-10 | 2026-03-12 | 1,167 | — | $0 | 0 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | S Sale | 2026-03-10 | 2026-03-12 | 14,000 | $70.00 | $980.0K | 8,000 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | M Exercise | 2026-03-10 | 2026-03-12 | 1,167 | $33.63 | $39.2K | 9,167 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | M Exercise | 2026-03-10 | 2026-03-12 | 14,000 | $33.63 | $470.8K | 22,000 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | S Sale | 2026-03-10 | 2026-03-12 | 1,167 | $70.00 | $81.7K | 8,000 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | S Sale | 2026-03-05 | 2026-03-09 | 6,333 | $63.38 | $401.4K | 8,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2026-03-03 | 2026-03-04 | 3,000 | $39.67 | $119.0K | 13,300 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | A Award deriv | 2026-01-02 | 2026-01-06 | 3,475 | — | $0 | 3,475 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | A Award | 2026-01-02 | 2026-01-06 | 4,000 | — | $0 | 12,000 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | G Gift | 2025-11-20 | 2025-11-21 | 867 | — | $0 | 8,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2025-06-11 | 2025-06-13 | 10,350 | — | $0 | 10,350 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award | 2025-06-11 | 2025-06-13 | 6,900 | — | $0 | 16,300 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | S Sale | 2025-03-13 | 2025-03-17 | 5,000 | $54.00 | $270.0K | 8,867 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | A Award deriv | 2025-01-03 | 2025-01-07 | 8,800 | — | $0 | 8,800 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | A Award | 2025-01-03 | 2025-01-07 | 4,000 | — | $0 | 13,867 | SEC↗ |
| CTLT Catalent, Inc. | D To issuer | 2024-12-18 | 2024-12-18 | 12,635 | — | $0 | 0 | SEC↗ |
| CTLT Catalent, Inc. | A Award | 2024-10-30 | 2024-11-01 | 4,663 | — | $0 | 12,635 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2024-06-07 | 2024-06-11 | 12,500 | — | $0 | 12,500 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award | 2024-06-07 | 2024-06-11 | 3,400 | — | $0 | 9,400 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise deriv | 2024-03-28 | 2024-04-02 | 17,500 | — | $0 | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2024-03-28 | 2024-04-02 | 17,500 | $46.38 | $811.6K | 6,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise | 2024-03-28 | 2024-04-02 | 17,500 | $18.29 | $320.1K | 23,500 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | A Award deriv | 2024-02-15 | 2024-02-16 | 10,000 | — | $0 | 10,000 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | A Award | 2024-02-15 | 2024-02-16 | 4,000 | — | $0 | 9,867 | SEC↗ |
| CTLT Catalent, Inc. | A Award | 2023-10-27 | 2023-10-31 | 6,993 | — | $0 | 7,972 | SEC↗ |
| CTLT Catalent, Inc. | A Award | 2023-08-28 | 2023-08-30 | 979 | — | $0 | 979 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2023-06-16 | 2023-06-21 | 17,500 | — | $0 | 17,500 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award | 2023-06-16 | 2023-06-21 | 6,000 | — | $0 | 6,000 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | D To issuer deriv | 2023-03-02 | 2023-03-02 | 8,000 | — | $0 | 0 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | D To issuer deriv | 2023-03-02 | 2023-03-02 | 8,000 | — | $0 | 0 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | D To issuer deriv | 2023-03-02 | 2023-03-02 | 8,000 | — | $0 | 0 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | D To issuer deriv | 2023-03-02 | 2023-03-02 | 5,500 | — | $0 | 0 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | D To issuer deriv | 2023-03-02 | 2023-03-02 | 5,500 | — | $0 | 0 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | D To issuer deriv | 2023-03-02 | 2023-03-02 | 11,000 | — | $0 | 0 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | A Award deriv | 2023-01-05 | 2023-01-09 | 10,000 | — | $0 | 10,000 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | A Award | 2023-01-05 | 2023-01-09 | 4,000 | — | $0 | 5,867 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | S Sale | 2022-08-09 | 2022-08-11 | 2,296 | $51.62 | $118.5K | 1,867 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award deriv | 2022-06-24 | 2022-06-28 | 8,000 | — | $0 | 8,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2022-06-17 | 2022-06-21 | 17,500 | — | $0 | 17,500 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | A Award deriv | 2022-01-07 | 2022-01-11 | 12,000 | — | $0 | 12,000 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | A Award | 2022-01-07 | 2022-01-11 | 3,200 | — | $0 | 4,163 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | S Sale | 2021-08-13 | 2021-08-17 | 1,650 | $40.06 | $66.1K | 963 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award deriv | 2021-06-24 | 2021-06-28 | 8,000 | — | $0 | 8,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2021-06-22 | 2021-06-23 | 17,500 | — | $0 | 17,500 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | A Award deriv | 2021-01-06 | 2021-01-08 | 10,000 | — | $0 | 10,000 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | A Award | 2021-01-06 | 2021-01-08 | 1,650 | — | $0 | 2,613 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | S Sale | 2020-12-08 | 2020-12-10 | 687 | $62.52 | $43.0K | 963 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award deriv | 2020-06-19 | 2020-06-19 | 8,000 | — | $0 | 8,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2020-06-19 | 2020-06-22 | 12,500 | — | $0 | 12,500 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | A Award deriv | 2020-01-29 | 2020-01-31 | 10,000 | — | $0 | 10,000 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | A Award | 2020-01-29 | 2020-01-31 | 1,650 | — | $0 | 1,650 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2019-07-15 | 2019-07-16 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award deriv | 2019-06-21 | 2019-06-25 | 5,500 | — | $0 | 5,500 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | A Award deriv | 2019-01-22 | 2019-01-24 | 14,000 | — | $0 | 14,000 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | A Award deriv | 2018-12-14 | 2018-12-18 | 14,000 | — | $0 | 14,000 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | A Award deriv | 2018-12-14 | 2018-12-18 | 1,167 | — | $0 | 1,167 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award deriv | 2018-06-18 | 2018-06-18 | 5,500 | — | $0 | 5,500 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award deriv | 2018-06-08 | 2018-06-11 | 11,000 | — | $0 | 11,000 | SEC↗ |